Semaglutide D Dose 3

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Healthy VolunteersObesityType 2 Diabetes

Phase 1

A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People

CompletedNCT05227196

Novo Nordisk A/SHealthy Volunteers, Type 2 Diabetes

Start: 2022-02-04End: 2023-08-08Updated: 2024-09-19

A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity

CompletedNCT05236517

Novo Nordisk A/SObesity

Start: 2022-02-08End: 2022-11-07Updated: 2024-09-19

Related Papers

A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants.

2024-12-213 citations